S

Synektik Spólka Akcyjna
SNT

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
PLN2.41B
EV
PLN2.37B
Shares Outstanding
8.53M
Beta
0.89
Industry
Medical - Devices

Wall Street View

Analyst Rating
BUY
Analyst Target Price
Number of Analysts
4
P/E 2026E
14.79x
P/Revenue 2026E
2.65x

Historical 3Y Growth Rate

Revenue
EPS
Operating Cash Flow
Free Cash Flow

Forecasted 3Y Growth Rate

Revenue
EPS
Operating Cash Flow
Free Cash Flow

Margins & Returns

Gross Margin 2026E
39.50%
Net Profit Margin 2026E
19.02%
ROE 2026E
66.33%
ROCE 2025
60.94%

Dividends

DPS 2026E
PLN10.62
Payout Ratio 2026E
55.57%
Div. Yield 2026E
3.75%
DPS Last 3Y CAGR

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Synektik Spólka Akcyjna

gainify

S

Synektik Spólka Akcyjna

SNT

Synektik Spólka Akcyjna provides products, services, and IT solutions for surgery, diagnostic imaging, and nuclear medicine applications in Poland. The company sells medical equipment used in diagnostics and therapy, and nuclear medicine. It is also involved in develo...

Sector

Healthcare

Industry

Medical - Devices

CEO

Kozanecki, Cezary

Employees

231

IPO Date

2011-08-01

Headquarters

ul. JOzefa Piusa Dziekonskiego 3, Warsaw 00-728, Poland

📊 Stock Price & Performance

The last closing price of Synektik Spólka Akcyjna (SNT) is PLN283.20, reflecting a +1.14% change from the prior session. Last updated: December 30, 2025 at 10:53 AM Eastern Time

Review the recent SNT stock performance trends:Past 1 Month: Synektik Spólka Akcyjna (SNT) shares have +0.57%.Past 3 Months: The stock has +12.14%.Past 6 Months: SNT shares have +50.32%. Last updated: January 1, 2026 at 12:20 AM Eastern Time

Over the last year, Synektik Spólka Akcyjna (SNT) has established a 52-week price range between a high of PLN287.00 and a low of PLN180.20. This metric is essential for assessing the stock's annual volatility. Last updated: January 1, 2026 at 12:20 AM Eastern Time

Synektik Spólka Akcyjna (SNT) is considered a medium volatility stock. It has a beta of 0.89, which means it typically moves 0.89 times as much as the broader market. Over the past 52 weeks, SNT has traded within a PLN180.20 – PLN287.00 range. Last updated: January 1, 2026 at 12:20 AM Eastern Time

Based on current SNT analyst forecasts and market assumptions, the consensus price target for Synektik Spólka Akcyjna (SNT) is PLN273.40 for 2027. Relative to the current price of PLN283.20, this implies a potential downside of -3.26%. Price targets reflect forward-looking estimates based on information available at the time and are inherently subject to change as underlying assumptions, company fundamentals, or market conditions evolve. Last updated: January 1, 2026 at 12:20 AM Eastern Time

A PLN1,000 investment in Synektik Spólka Akcyjna 5 years ago, when the stock was trading around PLN27.36, would be worth approximately PLN10352.10 today, based solely on share price performance (excluding dividends). This represents a total return of 935.21% over the period, equivalent to a compound annual growth rate (CAGR) of 59.59%. Past performance reflects historical price movements only and does not imply future results. Last updated: January 1, 2026 at 12:20 AM Eastern Time

💰 Financial Metrics & Reports

The current Synektik Spólka Akcyjna (SNT) market capitalization is approximately PLN2.41B, based on its latest share price and shares outstanding. Market capitalization represents the total market value of a company's equity and is calculated by multiplying the current stock price by the number of shares outstanding. As a result, Synektik Spólka Akcyjna's market cap fluctuates with changes in its share price and share count. Last updated: January 1, 2026 at 12:20 AM Eastern Time

In the most recently reported quarter, Synektik Spólka Akcyjna (SNT) generated PLN199.24M in revenue, representing a +40.49% year over year change. Quarterly revenue results and expectations reflect underlying demand trends, pricing dynamics, product or service mix, seasonality, and broader macroeconomic conditions. Actual results may differ from consensus estimates as new information becomes available. Last updated: January 1, 2026 at 4:30 AM Eastern Time

In the most recently reported fiscal year, Synektik Spólka Akcyjna (SNT) generated net income of PLN102.19M, compared with PLN84.64M in the prior fiscal year, representing a +20.75% year over year change. For the upcoming fiscal year, analyst consensus currently estimates net income of PLN173.02M. Net income may be positive or negative and can fluctuate materially from year to year due to changes in operating performance, non-recurring or one-time items, accounting treatments, capital structure, and broader macroeconomic conditions. Last updated: January 1, 2026 at 4:30 AM Eastern Time

According to its latest quarterly filing, Synektik Spólka Akcyjna (SNT) reported EBITDA of PLN54.60M, representing a +84.11% year over year change. EBITDA is a non-GAAP measure and does not account for depreciation, amortization, interest expense, taxes, or capital expenditures. As a result, it should be considered alongside other financial metrics when assessing operating performance. Actual results may differ from estimates as company-specific or macroeconomic conditions evolve. Last updated: January 1, 2026 at 4:30 AM Eastern Time

As of the most recent reporting period, the company's debt-to-equity ratio stands at 0.18x, calculated as total debt divided by total shareholders' equity. A lower debt-to-equity ratio generally indicates a more conservative capital structure with less reliance on external borrowing, while a higher ratio suggests greater financial leverage and potentially higher sensitivity to interest rates, refinancing conditions, and earnings volatility. The debt-to-equity ratio should be interpreted in the context of the company's industry, business model, cash flow stability, and balance sheet composition. Last updated: January 1, 2026 at 4:30 AM Eastern Time

Based on the latest available data, Synektik Spólka Akcyjna (SNT) is currently trading at a last twelve months (LTM) P/E ratio of 23.48x. The P/E ratio reflects how much investors are willing to pay today for a dollar of earnings and can vary meaningfully over time due to changes in profitability, growth expectations, margin outlook, and earnings volatility. Last updated: January 1, 2026 at 4:30 AM Eastern Time

📅 Earnings & Dividends

Synektik Spólka Akcyjna (SNT) is currently scheduled to report its next earnings results on February 2, 2026. Earnings dates are subject to change and may be updated by the company with limited notice. Investors typically monitor upcoming earnings releases closely, as they can result in increased volatility depending on reported results, forward guidance, and management commentary. Last updated: January 1, 2026 at 12:20 AM Eastern Time

In the most recently reported quarter, Synektik Spólka Akcyjna (SNT) revenue was PLN199.24M, compared with analyst consensus expectations of PLN191.80M, representing a +3.88% revenue surprise versus expectations. Earnings per share (EPS) for the quarter were PLN3.71. Revenue and EPS surprises may be positive or negative and can influence near-term stock performance depending on expectations, forward guidance, and broader market and sector conditions. For a detailed history of analyst expectations versus reported results, view the full estimates vs. actuals track record here: 👉 Estimates vs. Actuals Last updated: January 1, 2026 at 4:30 AM Eastern Time

📈 Analyst Information

Analyst assessments of whether Synektik Spólka Akcyjna (SNT) consensus price target is overvalued or undervalued are generally expressed relative to consensus valuation frameworks and price targets, rather than as an absolute judgment.Current share price: PLN283.20Consensus price target: PLN273.40Implied return: -3.26% An implied return above current levels indicates that, on average, analysts view the stock as trading below their estimated fair value. Conversely, an implied return below current levels suggests the stock may be fully valued or priced above consensus expectations. This content is for informational purposes only and does not constitute investment advice. Last updated: January 1, 2026 at 4:30 AM Eastern Time

Based on the latest available analyst coverage, Synektik Spólka Akcyjna (SNT) currently carries a Buy consensus rating. Analysts' average SNT price target is PLN273.40. Relative to the current share price of PLN283.20, this suggests a potential price change of approximately -3.26%. Analyst views are forward-looking estimates and should not be considered investment advice. Last updated: January 1, 2026 at 4:30 AM Eastern Time

Like other publicly traded stocks, Synektik Spólka Akcyjna (SNT) shares are bought and sold on stock exchanges such as WSE and other supported markets, depending on the listing. The most common way to buy shares is through an online brokerage account. To get started, you typically need to: Open an account with a licensed stock brokerComplete the broker's verification processFund your accountPlace a buy order for Synektik Spólka Akcyjna (SNT) shares Trading involves risk, and investors should consider their financial objectives and risk tolerance before investing.

ℹ️ Company Information

At the top right of this page, you'll see a star icon labeled Add to watchlist. Click it to add SNT to your watchlist.

Synektik Spólka Akcyjna trades under the ticker symbol SNT on the WSE stock exchange. The ticker SNT is used to identify the company's common stock across trading platforms, market data providers, and regulatory filings.

As of the most recently reported period, Synektik Spólka Akcyjna (SNT) employs approximately 231 people worldwide. Reported employee figures may fluctuate over time due to hiring activity, restructuring, automation initiatives, or changes in business strategy. Headcount data is typically disclosed in company filings and reflects full-time employees unless otherwise stated. Last updated: January 1, 2026 at 12:20 AM Eastern Time

Synektik Spólka Akcyjna (SNT) operates in a highly competitive market with companies that often have different business models, geographic exposure, and end markets. While no two companies are identical, the following firms are generally considered the closest Synektik Spólka Akcyjna (SNT) stock peers based on overlapping products, services, and competitive dynamics:Celon Pharma (CLN)Selvita (SLV)Ryvu Therapeutics (RVU)RaySearch Laboratories (RAY B)Captor Therapeutics Spolka Akcyjna (CTX)NEUCA (NEU)Molecure (MOC)NNIT (NNIT)Craneware (CRW)HeartFlow (HTFL) These peers may differ in size, business mix, financial profile, and strategic focus, but they are commonly referenced due to overlapping markets, customer segments, or competitive positioning relative to Synektik Spólka Akcyjna.

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2026 Gainify. All rights reserved.